key: cord-0745281-8tgichf6
authors: Ishizuka, K; Katayama, K; Kaji, Y; Tawara, J; Ohira, Y
title: Non-episodic angioedema with eosinophilia after BNT162b2 mRNA COVID-19 vaccination
date: 2021-09-21
journal: QJM
DOI: 10.1093/qjmed/hcab245
sha: c823bb7d91e4e8fc749444b49183f25b30dc30e1
doc_id: 745281
cord_uid: 8tgichf6

nan

A 77-year-old Japanese woman presented with peripheral oedema following COVID-19 vaccination. Three weeks before, the day after the second dose of BNT162b2 mRNA COVID-19 vaccination, she presented with low-grade fever, peripheral oedema and arthralgia of the bilateral foot joint. Fever and arthralgia were relieved spontaneously within a week. Since there was no improvement in the peripheral oedema, she was referred to our department. Her medical history revealed type 2 diabetes mellitus and dyslipidaemia, for which she had been prescribed 500 mg/day of metformin and 10 mg/day of atorvastatin. Physical examination revealed symmetrical non-pitting oedema of her legs (Figure 1a ). Laboratory tests showed blood eosinophilia (3750/ll). The serum IgM level was within normal. Non-episodic angioedema with eosinophilia (NEAE) was diagnosed. Her symptoms improved quickly with prednisolone administration (20 mg/day) (Figure 1b) . She has been recurrence-free after tapering off prednisolone.

Angioedema with eosinophilia is of two types: episodic angioedema with eosinophilia (EAE; Gleich's syndrome) and NEAE. 1-3 EAE has been reported mainly in Europe and the USA, whereas NEAE in Korea and Japan. 4 EAE is characterized by recurrent episodes of angioedema, urticaria, fever and increased body weight, with markedly high peripheral blood eosinophil count and serum IgM levels. 1,2 NEAE is characterized by a single episode of persistent oedema of the extremities, peripheral eosinophilia, transient arthralgia, lack of increased serum IgM levels and a less severe clinical course than that of EAE. 2,3 NEAE can occur after influenza vaccination; however, NEAE after COVID-19 vaccination has not been previously reported. 5 NEAE is also characterized by the effectiveness of low-dose prednisone or spontaneous remission within 2-3 months. 2, 3 In conclusion, non-pitting oedema of the extremities with eosinophilia should be considered eosinophilic angioedema, which can occur after COVID-19 vaccination. 

Episodic angioedema associated with eosinophilia

Nonepisodic angioedema with eosinophilia: a report of two cases and a review of the literature

Nonepisodic angioedema associated with eosinophilia: report of 4 cases and review of 33 young female patients reported in Japan

Non-episodic angioedema with eosinophilia successfully treated with reslizumab

A case of non-episodic angioedema with eosinophilia induced by influenza vaccine